The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation. Blood 2008 Apr 01;111(7):3901-2
Date
03/26/2008Pubmed ID
18362217DOI
10.1182/blood-2008-01-132050Scopus ID
2-s2.0-43549086236 (requires institutional sign-in at Scopus site) 43 CitationsAuthor List
Hamadani M, Awan FT, Devine SMAuthor
Mehdi Hamadani MBBS Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Acute DiseaseAdult
Aged
Disease-Free Survival
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Leukemia
Male
Middle Aged
Retrospective Studies
Survival Rate
Transplantation, Homologous
